Proposing a novel approach for the long-term use of monthly paliperidone palmitate: adjusting injection dose versus adjusting injection interval

Author:

Sánchez-Alonso Sergio12ORCID,Baca-García Enrique12345ORCID,Ovejero Santiago16,de Leon Jose78ORCID,Schoretsanitis Georgios91011ORCID

Affiliation:

1. Department of Psychiatry, Hospital Fundación Jiménez Díaz, Madrid, Spain

2. Department of Personalidad, Evaluación y Psicología Clínica, Faculty of Psychology, Complutense University of Madrid, Madrid, Spain

3. Spanish Network for Research in Mental Health (CIBERSAM), Instituto de Salud, Carlos III, Madrid, Spain

4. Department of Psychology, Universidad Católica del Maule, Talca, Chile

5. Department of Psychiatry, Centre Hospitalier Universitaire de Nîmes, Nîmes, France

6. Department of Psychiatry, Autonomous University of Madrid, Madrid, Spain

7. Mental Health Research Center at Eastern State Hospital, Lexington, KY, USA

8. Biomedical Research Centre in Mental Health Net (CIBERSAM), Santiago Apostol Hospital, University of the Basque Country, Vitoria, Spain

9. Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland

10. The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, NY, USA

11. Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA

Funder

CIBER -Consorcio Centro de Investigación Biomédica en Red

Instituto de Salud Carlos III

European Regional Development Fund

Ministerio de Ciencia e Innovación/a Agencia Estatal de Investigación

Fundació La Marató

CaixaResearch Health

Publisher

Informa UK Limited

Reference14 articles.

1. xeplion-epar-public-assessment-report_en.pdf [Internet]. [cited 2023 Sep 15]. Available from: https://www.ema.europa.eu/en/documents/assessment-report/xeplion-epar-public-assessment-report_en.pdf

2. Dosing and Switching Strategies for Paliperidone Palmitate

3. Serum concentration of paliperidone palmitate administered every 3 weeks;Cohen JY;Psychopharmacol Bull,2019

4. Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database

5. A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting paliperidone

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3